# Atropine Eyedrops for Myopia Progression in Children and Adolescents (MODERATO STUDY)

> **NCT07028827** · PHASE3 · RECRUITING · sponsor: **Ocus Innovation Ireland Limited** · enrollment: 234 (estimated)

## Conditions studied

- Myopia

## Interventions

- **DRUG:** 0.05% atropine eye drops
- **DRUG:** 0.025% atropine eye drops
- **DRUG:** placebo eye drops

## Key facts

- **NCT ID:** NCT07028827
- **Lead sponsor:** Ocus Innovation Ireland Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-01
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 234 (ESTIMATED)
- **Last updated:** 2026-02-11

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07028827

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07028827, "Atropine Eyedrops for Myopia Progression in Children and Adolescents (MODERATO STUDY)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07028827. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*